Le. Gustafsson et al., NEUROGENIC VASODILATION IN RABBIT HINDLIMB MEDIATED BY TACHYKININS AND NITRIC-OXIDE, Journal of cardiovascular pharmacology, 23(4), 1994, pp. 612-617
We investigated the role of nitric oxide (NO) in the mediation of nerv
e stimulation-induced vasodilation in skeletal muscle. Hindlimb blood
flow and vascular resistance were measured in pentobarbital-anesthetiz
ed, paralyzed, and guanethidine-treated rabbits. Centrifugal electrica
l stimulation of the sciatic nerve bundle induced reproducible, freque
ncy-, voltage-, and pulse duration-dependent decrements in vascular re
sistance. The tachykinin antagonist CP-96,345 (I mg/kg intravenously,
i.v.) attenuated the vasodilation induced by intraarterially (i.a.) ad
ministered substance P but not by adenosine. Furthermore, CP-96,345 at
tenuated the decrease in vascular resistance in response to nerve stim
ulation, from 22.9 +/- 3.2 to 4.5 +/- 4.1% of control resting resistan
ce (p < 0.005), without affecting basal vascular resistance. An inhibi
tor of NO formation, N(omega)-nitro-L-arginine methyl ester (L-NAME, 3
0 mg/kg i.v.), increased vascular resistance from 6.1 +/- 0.5 to 9.1 /- 1.2 resistance units (p < 0.05) and significantly attenuated the va
scular response to i.a. administered substance P but not adenosine. Fi
nally, nerve stimulation-induced reduction in vascular resistance was
attenuated by L-NAME, from 22.6 +/- 2.7 to 7.0 +/- 1.0% of control (p
< 0.001). These findings suggest that tachykinins and NO are involved
in mediation of vasodilation in response to the present type of nerve
stimulation. The data are consistent with the hypothesis that NO is pr
oduced subsequent to neural release of tachykinin-type transmitter(s).